Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Test-retest reliability and minimal detectable change of ankle kinematics and spatiotemporal parameters in MS population.

Andreopoulou G, Mahad DJ, Mercer TH, van der Linden ML.

Gait Posture. 2019 Oct;74:218-222. doi: 10.1016/j.gaitpost.2019.09.015. Epub 2019 Sep 16.

PMID:
31561120
2.

Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.

Klotz L, Eschborn M, Lindner M, Liebmann M, Herold M, Janoschka C, Torres Garrido B, Schulte-Mecklenbeck A, Gross CC, Breuer J, Hundehege P, Posevitz V, Pignolet B, Nebel G, Glander S, Freise N, Austermann J, Wirth T, Campbell GR, Schneider-Hohendorf T, Eveslage M, Brassat D, Schwab N, Loser K, Roth J, Busch KB, Stoll M, Mahad DJ, Meuth SG, Turner T, Bar-Or A, Wiendl H.

Sci Transl Med. 2019 May 1;11(490). pii: eaao5563. doi: 10.1126/scitranslmed.aao5563.

PMID:
31043571
3.

A Method to Detect Cytochrome c Oxidase Activity and Mitochondrial Proteins in Oligodendrocytes.

Campbell GR, Mahad DJ.

Methods Mol Biol. 2019;1936:333-342. doi: 10.1007/978-1-4939-9072-6_19.

PMID:
30820908
4.

Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis.

Campbell G, Mahad DJ.

FEBS Lett. 2018 Apr;592(7):1113-1121. doi: 10.1002/1873-3468.13013. Epub 2018 Mar 25. Review.

5.

Oxidative Injury and Iron Redistribution Are Pathological Hallmarks of Marmoset Experimental Autoimmune Encephalomyelitis.

Dunham J, Bauer J, Campbell GR, Mahad DJ, van Driel N, van der Pol SMA, 't Hart BA, Lassmann H, Laman JD, van Horssen J, Kap YS.

J Neuropathol Exp Neurol. 2017 Jun 1;76(6):467-478. doi: 10.1093/jnen/nlx034.

PMID:
28505283
6.

Loss of protohaem IX farnesyltransferase in mature dentate granule cells impairs short-term facilitation at mossy fibre to CA3 pyramidal cell synapses.

Booker SA, Campbell GR, Mysiak KS, Brophy PJ, Kind PC, Mahad DJ, Wyllie DJ.

J Physiol. 2017 Mar 15;595(6):2147-2160. doi: 10.1113/JP273581.

7.

Mitochondrial fission augments capsaicin-induced axonal degeneration.

Chiang H, Ohno N, Hsieh YL, Mahad DJ, Kikuchi S, Komuro H, Hsieh ST, Trapp BD.

Acta Neuropathol. 2015 Jan;129(1):81-96. doi: 10.1007/s00401-014-1354-3. Epub 2014 Oct 17.

8.

The central role of mitochondria in axonal degeneration in multiple sclerosis.

Campbell GR, Worrall JT, Mahad DJ.

Mult Scler. 2014 Dec;20(14):1806-13. doi: 10.1177/1352458514544537. Epub 2014 Aug 13. Review.

PMID:
25122475
9.

Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons.

Ohno N, Chiang H, Mahad DJ, Kidd GJ, Liu L, Ransohoff RM, Sheng ZH, Komuro H, Trapp BD.

Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9953-8. doi: 10.1073/pnas.1401155111. Epub 2014 Jun 23.

10.

Metabolic support of axons by oligodendrocytes: Implications for multiple sclerosis.

Campbell GR, Mahad DJ.

Mult Scler Relat Disord. 2014 Jan;3(1):28-30. doi: 10.1016/j.msard.2013.06.008. Epub 2013 Aug 4. No abstract available.

PMID:
25877969
11.

Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.

Witte ME, Mahad DJ, Lassmann H, van Horssen J.

Trends Mol Med. 2014 Mar;20(3):179-87. doi: 10.1016/j.molmed.2013.11.007. Epub 2013 Dec 24. Review.

PMID:
24369898
12.

No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis.

Campbell GR, Reeve AK, Ziabreva I, Reynolds R, Turnbull DM, Mahad DJ.

Mult Scler. 2013 Dec;19(14):1858-66. doi: 10.1177/1352458513490547. Epub 2013 Jun 20.

13.

Mitochondrial DNA deletions and depletion within paraspinal muscles.

Campbell GR, Reeve A, Ziabreva I, Polvikoski TM, Taylor RW, Reynolds R, Turnbull DM, Mahad DJ.

Neuropathol Appl Neurobiol. 2013 Jun;39(4):377-89. doi: 10.1111/j.1365-2990.2012.01290.x.

14.

Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.

Campbell GR, Kraytsberg Y, Krishnan KJ, Ohno N, Ziabreva I, Reeve A, Trapp BD, Newcombe J, Reynolds R, Lassmann H, Khrapko K, Turnbull DM, Mahad DJ.

Acta Neuropathol. 2012 Aug;124(2):209-20. doi: 10.1007/s00401-012-1001-9. Epub 2012 Jun 12.

15.

Clonal expansion of mitochondrial DNA deletions and the progression of multiple sclerosis.

Campbell GR, Mahad DJ.

CNS Neurol Disord Drug Targets. 2012 Aug;11(5):589-97. Review.

PMID:
22583438
16.

Mitochondrial changes within axons in multiple sclerosis: an update.

Campbell GR, Ohno N, Turnbull DM, Mahad DJ.

Curr Opin Neurol. 2012 Jun;25(3):221-30. doi: 10.1097/WCO.0b013e3283533a25. Review.

PMID:
22543429
17.

Loss of myelin-associated glycoprotein in kearns-sayre syndrome.

Lax NZ, Campbell GR, Reeve AK, Ohno N, Zambonin J, Blakely EL, Taylor RW, Bonilla E, Tanji K, DiMauro S, Jaros E, Lassmann H, Turnbull DM, Mahad DJ.

Arch Neurol. 2012 Apr;69(4):490-9. doi: 10.1001/archneurol.2011.2167.

18.

Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis.

Zambonin JL, Zhao C, Ohno N, Campbell GR, Engeham S, Ziabreva I, Schwarz N, Lee SE, Frischer JM, Turnbull DM, Trapp BD, Lassmann H, Franklin RJ, Mahad DJ.

Brain. 2011 Jul;134(Pt 7):1901-13. doi: 10.1093/brain/awr110.

19.

Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.

Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ, Reynolds R, Howell O, Lassmann H, Turnbull DM, Mahad DJ.

Ann Neurol. 2011 Mar;69(3):481-92. doi: 10.1002/ana.22109. Epub 2010 Nov 8.

20.

Mitochondrial changes associated with demyelination: consequences for axonal integrity.

Campbell GR, Mahad DJ.

Mitochondrion. 2012 Mar;12(2):173-9. doi: 10.1016/j.mito.2011.03.007. Epub 2011 Mar 23. Review.

PMID:
21406249
21.

Mitochondria as crucial players in demyelinated axons: lessons from neuropathology and experimental demyelination.

Campbell GR, Mahad DJ.

Autoimmune Dis. 2011 Feb 8;2011:262847. doi: 10.4061/2011/262847.

22.

Identification and investigation of mitochondria lacking cytochrome c oxidase activity in axons.

Zambonin J, Engeham S, Campbell GR, Ziabreva I, Beadle NE, Taylor RW, Mahad DJ.

J Neurosci Methods. 2010 Sep 30;192(1):115-20. doi: 10.1016/j.jneumeth.2010.07.022. Epub 2010 Jul 24.

PMID:
20659500
23.

Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease.

Sisková Z, Mahad DJ, Pudney C, Campbell G, Cadogan M, Asuni A, O'Connor V, Perry VH.

Am J Pathol. 2010 Sep;177(3):1411-21. doi: 10.2353/ajpath.2010.091037. Epub 2010 Jul 22.

24.

Detection of cytochrome c oxidase activity and mitochondrial proteins in single cells.

Mahad DJ, Ziabreva I, Campbell G, Laulund F, Murphy JL, Reeve AK, Greaves L, Smith KJ, Turnbull DM.

J Neurosci Methods. 2009 Nov 15;184(2):310-9. doi: 10.1016/j.jneumeth.2009.08.020. Epub 2009 Aug 31.

PMID:
19723540
25.

Mitochondrial changes within axons in multiple sclerosis.

Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS, Lassmann H, Turnbull DM.

Brain. 2009 May;132(Pt 5):1161-74. doi: 10.1093/brain/awp046. Epub 2009 Mar 17.

26.

Primary spinal cord neurodegeneration in Leber hereditary optic neuropathy.

Jaros E, Mahad DJ, Hudson G, Birchall D, Sawcer SJ, Griffiths PG, Sunter J, Compston DA, Perry RH, Chinnery PF.

Neurology. 2007 Jul 10;69(2):214-6. No abstract available.

PMID:
17620555
27.

CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.

Kantarci OH, Morales Y, Ziemer PA, Hebrink DD, Mahad DJ, Atkinson EJ, Achenbach SJ, De Andrade M, Mack M, Ransohoff RM, Lassmann H, Bruck W, Weinshenker BG, Lucchinetti CF.

J Neuroimmunol. 2005 Dec;169(1-2):137-43. Epub 2005 Sep 22.

PMID:
16182378
28.

Aciclovir induced posterior leucoencephalopathy.

Mahad DJ, Helldén A, Jarvis J, Mitra D, Gholkar A, Chinnery PF.

J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1308-9. No abstract available. Erratum in: J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1747. Mahad, D [corrected to Mahad, DJ].

29.

Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination.

Mahad DJ, Staugaitis S, Ruggieri P, Parisi J, Kleinschmidt-Demasters BK, Lassmann H, Ransohoff RM.

J Neurol Sci. 2005 Jan 15;228(1):3-5. Epub 2004 Nov 2.

PMID:
15607202
30.

Expression of CCR7 in multiple sclerosis: implications for CNS immunity.

Kivisäkk P, Mahad DJ, Callahan MK, Sikora K, Trebst C, Tucky B, Wujek J, Ravid R, Staugaitis SM, Lassmann H, Ransohoff RM.

Ann Neurol. 2004 May;55(5):627-38.

PMID:
15122702
31.

Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions.

Mahad DJ, Trebst C, Kivisäkk P, Staugaitis SM, Tucky B, Wei T, Lucchinetti CF, Lassmann H, Ransohoff RM.

J Neuropathol Exp Neurol. 2004 Mar;63(3):262-73.

PMID:
15055450
32.

Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin.

Kivisäkk P, Mahad DJ, Callahan MK, Trebst C, Tucky B, Wei T, Wu L, Baekkevold ES, Lassmann H, Staugaitis SM, Campbell JJ, Ransohoff RM.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8389-94. Epub 2003 Jun 26.

33.
34.

The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).

Mahad DJ, Ransohoff RM.

Semin Immunol. 2003 Feb;15(1):23-32. Review.

PMID:
12495638
35.
36.

Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis.

Mahad DJ, Howell SJ, Woodroofe MN.

J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):498-502.

Supplemental Content

Loading ...
Support Center